Synergistic Two-Step Inhibition Approach Using a Combination of Trametinib and Onvansertib in KRAS and TP53-mutated Colorectal Adenocarcinoma
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie（2024）
关键词
PLK1,MEK1/2,KRAS,TP53,Colorectal adenocarcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要